Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA

<h4>Background and Aims</h4> <p>Randomised trials have described the benefits of adalimumab [ADA] for ulcerative colitis [UC]; however, few data are available on health-related quality of life [HRQL] and health care costs in clinical practice.</p> <h4>Methods</h4>...

Full description

Bibliographic Details
Main Authors: Travis, S, Feagan, BG, Peyrin-Biroulet, L, Panaccione, R, Danese, S, Lazar, A, Robinson, AM, Petersson, J, Pappalardo, BL, Bereswill, M, Chen, N, Wang, S, Skup, M, Thakkar, RB, Chao, J
Format: Journal article
Published: Oxford University Press 2017